Smart Healthcare Technology for Alzheimer's Caregiver Support

N/A

Waitlist Available

Led By Karen M Rose, PhD

Research Sponsored by Ohio State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up daily through study completion, average of four months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to develop a solution that monitors a dementia patient's mood and stress, as well as the caregiver's behavior. The goal is to help improve familial interactions related to caregiving, which over time should reduce strain on caregivers.

Who is the study for?

This trial is for men and women aged 60-90 with documented dementia, including Alzheimer's, who live at home and speak English. Caregivers must be over 21, living with the patient, not paid for their care work, have functioning home Wifi, and experience a certain level of stress as measured by a clinical checklist.

What is being tested?

The study tests a smart healthcare system that monitors mood and stress in both patients with dementia and their caregivers. It uses machine learning to understand interaction dynamics and provides adaptive recommendations to improve caregiver-patient relationships.

What are the potential side effects?

Since this intervention involves monitoring systems rather than medications or invasive procedures, traditional physical side effects are not expected. However, there may be privacy concerns or emotional impacts from constant monitoring.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Acoustic Monitoring/Mood Classifier

Change in Caregiver Depression, Anxiety and Stress

Change in Caregiver Loneliness

+10 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Dementia/Caregiver DyadExperimental Treatment1 Intervention

All dementia/caregiver dyads will have in-home acoustic monitoring to classify mood and will be provided mindfulness-based stress reduction recommendations via a smart phone.

Do I qualify?Apply below to find out